SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-013049
Filing Date
2023-08-03
Accepted
2023-08-03 07:01:10
Documents
75
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q elev-20230630x10q.htm   iXBRL 10-Q 2230052
2 EX-3.1 elev-20230630xex3d1.htm EX-3.1 9682
3 EX-31.1 elev-20230630xex31d1.htm EX-31.1 15579
4 EX-31.2 elev-20230630xex31d2.htm EX-31.2 15551
5 EX-32 elev-20230630xex32.htm EX-32 8151
  Complete submission text file 0001558370-23-013049.txt   8021093

Data Files

Seq Description Document Type Size
6 EX-101.SCH elev-20230630.xsd EX-101.SCH 51538
7 EX-101.CAL elev-20230630_cal.xml EX-101.CAL 38361
8 EX-101.DEF elev-20230630_def.xml EX-101.DEF 225935
9 EX-101.LAB elev-20230630_lab.xml EX-101.LAB 471833
10 EX-101.PRE elev-20230630_pre.xml EX-101.PRE 373416
69 EXTRACTED XBRL INSTANCE DOCUMENT elev-20230630x10q_htm.xml XML 1347131
Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 6463459464
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40523 | Film No.: 231137995
SIC: 2836 Biological Products, (No Diagnostic Substances)